Advisornet Financial’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.19K | Sell |
54
-16
| -23% | -$2.43K | ﹤0.01% | 1512 |
|
|
2025
Q1 | $10.5K | Sell |
70
-13
| -16% | -$1.96K | ﹤0.01% | 1372 |
|
|
2024
Q4 | $15.3K | Sell |
83
-7
| -8% | -$1.29K | ﹤0.01% | 1194 |
|
|
2024
Q3 | $17.7K | Sell |
90
-15
| -14% | -$2.96K | ﹤0.01% | 1235 |
|
|
2024
Q2 | $21.7K | Sell |
105
-14
| -12% | -$2.89K | ﹤0.01% | 1064 |
|
|
2024
Q1 | $32.2K | Buy |
119
+71
| +148% | +$19.2K | ﹤0.01% | 942 |
|
|
2023
Q4 | $11.3K | Buy |
48
+3
| +7% | +$709 | ﹤0.01% | 1274 |
|
|
2023
Q3 | $8.82K | Sell |
45
-8
| -15% | -$1.57K | ﹤0.01% | 1270 |
|
|
2023
Q2 | $11.1K | Buy |
53
+5
| +10% | +$1.05K | ﹤0.01% | 1295 |
|
|
2023
Q1 | $9.69K | Hold |
48
| – | – | ﹤0.01% | 1310 |
|
|
2022
Q4 | $10.5K | Sell |
48
-18
| -27% | -$3.92K | ﹤0.01% | 1281 |
|
|
2022
Q3 | $13K | Buy |
66
+3
| +5% | +$591 | ﹤0.01% | 1235 |
|
|
2022
Q2 | $13K | Sell |
63
-10
| -14% | -$2.06K | ﹤0.01% | 1263 |
|
|
2022
Q1 | $21K | Buy |
73
+10
| +16% | +$2.88K | ﹤0.01% | 1217 |
|
|
2021
Q4 | $24K | Hold |
63
| – | – | ﹤0.01% | 1234 |
|
|
2021
Q3 | $26K | Buy |
+63
| New | +$26K | ﹤0.01% | 1174 |
|
|
2018
Q3 | – | Sell |
-13
| Closed | -$1K | – | 1491 |
|
|
2018
Q2 | $1K | Buy |
+13
| New | +$1K | ﹤0.01% | 1442 |
|